Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

NCT03093909 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03093909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03093909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Recruiting
Start date
November 22, 2017
Completion date
November 30, 2027
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of bone and articular cartilage, malignant neoplasm of male genital organs, malignant neoplasm of respiratory and intrathoracic organ carcinoma, malignant neoplasms of female genital organs, malignant neoplasms of independent (primary) multiple sites, malignant neoplasms of lip oral cavity and pharynx, malignant neoplasms of mesothelial and soft tissue, malignant neoplasms of thyroid and other endocrine glands, malignant neoplasms of urinary tract, melanoma and other malignant neoplasms of skin